BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26234713)

  • 21. Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils.
    Creed RB; Goldberg MS
    Neuroscience; 2020 Jun; 437():64-75. PubMed ID: 32353461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of Neurobiological Changes in the Presymptomatic PINK1 Knockout Rat.
    Ferris CF; Morrison TR; Iriah S; Malmberg S; Kulkarni P; Hartner JC; Trivedi M
    J Parkinsons Dis; 2018; 8(2):281-301. PubMed ID: 29710734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.
    Oliveras-Salvá M; Macchi F; Coessens V; Deleersnijder A; Gérard M; Van der Perren A; Van den Haute C; Baekelandt V
    Neurobiol Aging; 2014 Nov; 35(11):2625-2636. PubMed ID: 25037286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats.
    Creed RB; Roberts RC; Farmer CB; McMahon LL; Goldberg MS
    Neurobiol Dis; 2021 Mar; 150():105246. PubMed ID: 33387634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy.
    Nguyen TT; Kim YJ; Lai TT; Nguyen PT; Koh YH; Nguyen LTN; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(4):1201-1217. PubMed ID: 35253778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.
    Grant LM; Barnett DG; Doll EJ; Leverson G; Ciucci M
    Behav Brain Res; 2015 Sep; 291():361-371. PubMed ID: 26026785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Developments in Genetic rat models of Parkinson's Disease.
    Creed RB; Goldberg MS
    Mov Disord; 2018 May; 33(5):717-729. PubMed ID: 29418019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
    Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic but not cholinergic neurodegeneration is correlated with gait disturbances in PINK1 knockout rats.
    DeAngelo VM; Hilliard JD; McConnell GC
    Behav Brain Res; 2022 Jan; 417():113575. PubMed ID: 34534596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
    Dave KD; De Silva S; Sheth NP; Ramboz S; Beck MJ; Quang C; Switzer RC; Ahmad SO; Sunkin SM; Walker D; Cui X; Fisher DA; McCoy AM; Gamber K; Ding X; Goldberg MS; Benkovic SA; Haupt M; Baptista MA; Fiske BK; Sherer TB; Frasier MA
    Neurobiol Dis; 2014 Oct; 70():190-203. PubMed ID: 24969022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of brainstem norepinephrine relative to vocal impairment and anxiety in the Pink1-/- rat model of Parkinson disease.
    Hoffmeister JD; Kelm-Nelson CA; Ciucci MR
    Behav Brain Res; 2021 Sep; 414():113514. PubMed ID: 34358571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat.
    Hoffmeister JD; Broadfoot CK; Schaen-Heacock NE; Lechner SA; Krasko MN; Nisbet AF; Russell J; Szot J; Glass TJ; Connor NP; Kelm-Nelson CA; Ciucci MR
    Brain Res; 2024 Aug; 1837():148958. PubMed ID: 38685371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein.
    Chen YH; Wu KJ; Hsieh W; Harvey BK; Hoffer BJ; Wang Y; Yu SJ
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34205689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.
    Zhou ZD; Saw WT; Ho PGH; Zhang ZW; Zeng L; Chang YY; Sun AXY; Ma DR; Wang HY; Zhou L; Lim KL; Tan EK
    Cell Mol Life Sci; 2022 Nov; 79(12):599. PubMed ID: 36409355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.